Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the ratprostate gland throughout life

Endocrinology

Volumn 153, Issue 1, 2012, Pages 42-55

  Tang, Wan Yee ^a,d   Morey, Lisa M ^a,e   Cheung, Yuk Yin ^a   Birch, Lynn ^c   Prins, Gail S ^c   Ho, Shuk Mei ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d The Johns Hopkins University   (United States)

^e CANISIUS COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BINDING PROTEIN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ESTRADIOL; HIPPOCALCIN LIKE 1 PROTEIN; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 4; NUCLEIC ACID BINDING PROTEIN; NUCLEOSOME BINDING PROTEIN 1; PHOSPHODIESTERASE 4D VARIANT 4 PROTEIN; PHOSPHODIESTERASE IV; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; DEMETHYLATION; DNA DEMETHYLATION; DNA METHYLATION; EPIGENETICS; EXPOSURE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CANCER; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; AZACITIDINE; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA PRIMERS; DNA-BINDING PROTEINS; ESTRADIOL; GENE EXPRESSION; HMGN PROTEINS; MALE; NERVE TISSUE PROTEINS; PHENOLS; PROMOTER REGIONS, GENETIC; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 84455188710     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1308     Document Type: Article

References (63)

1. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B 2004 Human prostate cancer risk factors. Cancer 101:2371-2490 (Pubitemid 39505434)
2. Brawley OW, Jani AB, Master V 2007 Prostate cancer and race. Curr Probl Cancer 31:211-225 (Pubitemid 46830809)
3. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, Rafnar T, Gudbjartsson D, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Blondal T, Stacey SN, Helgason A, Gunnarsdottir S, Olafsdottir A, Kristinsson KT, Birgisdottir B, Ghosh S, Thorlacius S, Magnusdottir D, Stefansdottir G, Kristjansson K, et al. 2007 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39:977-983 (Pubitemid 47185170)
4. Crawford ED 2003 Epidemiology of prostate cancer. Urology 62: 3-12 (Pubitemid 38050194)
5. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85 (Pubitemid 30451850)
6. Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E 1999 Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. Int J Cancer 83:743-749
7. Tang WY, Ho SM 2007 Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 8:173-182
8. Prins GS 2008 Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 15:649-656
9. Zhang X, Ho SM 2011 Epigenetics meets endocrinology. J Mol Endocrinol 46:R11-R32
10. Price D 1963 Comparative aspects of development and structure in the prostate. Natl Cancer Inst Monogr 12:1-27
11. Prins GS 1989 Differential regulation of androgen receptors in the separate rat prostate lobes: androgen independent expression in the lateral lobe. J Steroid Biochem 33:319-326 (Pubitemid 19236133)
12. Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley RA, Gluckman P, Godfrey K, Kirkwood T, Lahr MM, McNamara J, Metcalfe NB, Monaghan P, Spencer HG, Sultan SE 2004 Developmental plasticity and human health. Nature 430:419-421 (Pubitemid 38987896)
13. Cnattingius S, Lundberg F, Sandin S, Grönberg H, Iliadou A 2009 Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 18:2422-2426
14. Ekbom A, Wuu J, Adami HO, Lu CM, Lagiou P, Trichopoulos D, Hsieh C 2000 Duration of gestation and prostate cancer risk in offspring. Cancer Epidemiol Biomarkers Prev 9:221-223 (Pubitemid 30111948)
15. Ross RK, Henderson BE 1994 Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86:252-254
16. Ekbom A 1998 Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 8:237-244
17. Sequoia JS, Wright ME, McCarron P, Pietinen P, Taylor PR, Virtamo J, Albanes D 2006 A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 15:2174-2178 (Pubitemid 44877043)
18. Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G, Rifai N, Pollak MN, Agurs-Collins T, Platz EA 2009 Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18:1484-1491
19. Bonasio R, Tu S, Reinberg D 2010 Molecular signals of epigenetic states. Science 330:612-616
20. Berger SL 2009 Epigenetic inheritance and replicative cellular aging. In: Saddone-Corsi P, ed. Epigenetic control and neuronal function 1-5. Washington, DC: Society for Neuroscience
21. Jablonka E, Lamb MJ 2002 The changing concept of epigenetics. Ann NY Acad Sci 981:82-96 (Pubitemid 36127087)
22. Anway MD, Cupp AS, Uzumcu M, Skinner MK 2005 Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308:1466-1469 (Pubitemid 40791300)
23. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS 2006 Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632
24. Tang WY, Newbold R, Mardilovich K, Jefferson W, Cheng RY, Medvedovic M, Ho SM 2008 Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149:5922-5931
25. BraunewellKH2005 The darker side ofCa2+ signaling by neuronal Ca2+ -sensor proteins: from Alzheimer's disease to cancer. Trends Pharmacol Sci 26:345-351
26. Gonzalez GuerricoAM,JafferZM,Page RE, Braunewell KH, Chernoff J, Klein-Szanto AJ 2005 Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells. Oncogene 24:2307-2316 (Pubitemid 40546690)
27. Wickborn C, Klein-Szanto AJ, Schlag PM, Braunewell KH 2006 Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus. Mol Carcinog 45:572-581 (Pubitemid 44205097)
28. Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, Bassi DE, Jin F, Zhang J, Cairns P, Ibañez de Caceres I, Braunewell KH, Klein-Szanto AJ 2008 VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival. PLoS One 3:e1698
29. Qu J, Yan R, Chen J, Xu T, Zhou J, Wang M, Chen C, Yan Y, Lu Y 2011 HMGN5: a potential oncogene in gliomas. J Neurooncol 104:729-736
30. Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, Song G, He Q, Li XS, Zhou LQ 2011 The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells. Tumour Biol 32:931-939
31. Jiang N, Zhou LQ, Zhang XY 2010 Downregulation of the nucleosome- binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells. Asian J Androl 12:709-717
32. Song G, Zhou LQ, Weng M, He Q, He ZS, Hao JR, Pan BN,NaYQ. Zhonghua Yi Xue Za Zhi 2006 Expression of nucleosomal binding protein 1 in normal prostate, benign prostate hyperplasia, and prostate cancer and significance thereof. Zhonghua Yi Xue Za Zhi 86: 1962-1965
33. Prins GS, Ye SH, Birch L, Ho SM, Kannan K 2011 Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol. 31:1-9
34. Lee C, Prins GS, Henneberry MO, Grayhack JT 1981 Effect of estradiol on the rat prostate in the presence and absence of testosterone and pituitary. J Androl 2:293-299
35. Chang SM, Chung LW 1989 Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 125:2719-2727 (Pubitemid 19279464)
36. Ho SM, Leav I, Damassa D, Kwan PW, Merk FB, Seto HS 1988 Testosterone-mediated increase in 5α-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgenindependent prostate carcinoma of Noble rats. Cancer Res 48:609-614 (Pubitemid 18056529)
37. Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS 2010 Bisphenol- A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24:2273-2280
38. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA, Negishi M 1997 Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57:4356-4359 (Pubitemid 27413446)
39. Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC 2003 Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 38:78-84 (Pubitemid 37255143)
40. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521 (Pubitemid 24273695)
41. Ciullo I, Diez-Roux G, Di DomenicoM,Migliaccio A, Avvedimento EV 2001 cAMP signaling selectively influences Ras effectors pathways. Oncogene 20:1186-1192 (Pubitemid 32226244)
42. Rahrmann EP, Collier LS, Knutson TP, Doyal ME, Kuslak SL, Green LE, Malinowski RL, Roethe L, Akagi K, Waknitz M, Huang W, Largaespada DA, Marker PC 2009 Identification of PDE4D as a proliferation promoting factor in prostate cancer using a sleeping beauty transposon-based somatic mutagenesis screen. Cancer Res 69:4388-4397
43. Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P 2006 Immunohistochemical distribution of cAMP- and cGMPphosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 49:740-745 (Pubitemid 43374744)
44. NakhlaAM,Khan MS, Romas NP, RosnerW1994 Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 91:5402-5405 (Pubitemid 24174335)
45. Merkle D, Hoffmann R 2011 Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor. Cell Signal 23:507-515
46. Bustin M 2001 Chromatin unfolding and activation by HMGN(*) chromosomal proteins. Trends Biochem Sci 26:431-437 (Pubitemid 32607485)
47. Bustin M, Trieschmann L, Postnikov YV 1995 The HMG-14/-17 chromosomal protein family: architectural elements that enhance transcription from chromatin templates. Semin Cell Biol 6:247-255
48. Gerlitz G 2010 HMGNs, DNA repair and cancer. Biochim Biophys Acta 1799:80-85
49. Pogna EA, Clayton AL, Mahadevan LC 2010 Signalling to chromatin through post-translational modifications ofHMGN.Biochim Biophys Acta 1799:93-100
50. Rochman M, Malicet C, Bustin M 2010 HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. Biochim Biophys Acta 1799:86-92
51. Shirakawa H, Landsman D, Postnikov YV, BustinM2000 NBP-45, a novel nucleosomal binding protein with a tissue-specific and developmentally regulated expression. J Biol Chem 275:6368-6374 (Pubitemid 30129931)
52. Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M 2009 The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Mol Cell 35:642-656
53. Malicet C, Rochman M, Postnikov Y, BustinM2011 Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein. Mol Cell Biol 31:2742-2755
54. Newbold RR, Bullock BC, McLachlan JA 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50:7677-7681
55. Newbold RR, Banks EP, Bullock B, Jefferson WN 2001 Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 61:4325-4328 (Pubitemid 32685752)
56. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP 2005 DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19:667-678 (Pubitemid 41219442)
57. Nimura K, Ishida C, Koriyama H, Hata K, Yamanaka S, Li E, Ura K, Kaneda Y 2006 Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. Genes Cells 11: 1225-1237 (Pubitemid 44426210)
58. Reik W, Dean W, Walter J 2001 Epigenetic reprogramming in mammalian development. Science 293:1089-1093 (Pubitemid 32758081)
59. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP 1989 Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499-507 (Pubitemid 19203534)
60. Dhasarathy A, Wade PA 2008 The MBD protein family-reading an epigenetic mark? Mutat Res 647:39-43
61. Hamm S, Just G, Lacoste N, Moitessier N, Szyf M, Mamer O 2008 On the mechanism of demethylation of 5-methylcytosine in DNA. Bioorg Med Chem Lett 18:1046-1049 (Pubitemid 351179349)
62. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M 1999 Amammalian protein with specific demethylase activity for mCpG DNA. Nature 397:579-583
63. Kim MS, Kondo T, Takada I, Youn MY, Yamamoto Y, Takahashi S, Matsumoto T, Fujiyama S, Shirode Y, Yamaoka I, Kitagawa H, Takeyama K, Shibuya H, Ohtake F, Kato S 2009 DNA demethylation in hormone-induced transcriptional derepression. Nature 461:1007-1012